About Flare Therapeutics
Illuminating the Path to the Possible
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $85,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Series-B+ announced
- Capital Raise
Raised $82,000,000 · Series-A
- Milestone
Company founded
Cambridge, United States
- Milestone
Website domain registered
flaretx.com
Investors & Backers
Funding History
Founders & Leadership
Anna Protopapas
CEO
Brian DeSchuytner
Chief Financial Officer & Chief Business Officer
Doug Manion
Chief Executive Officer
Fraydoon Rastinejad
Founder
Jeanette W. Kohlbrenner
Interim Chief People Officer
Michaela Bowden
SVP, Biology & Translation
Mitchell Lazar
Founder
Robert Sims
Chief Scientific Officer and Co-Founder
Stephen Eck
Chief Medical Officer
Press Coverage & Sources
fundraisingfox.com/companies/flare-therapeutics
prnewswire.com/news-releases/flare-therapeutics-announces-oversubscribed-123-million-series-b-financing-301777965.html
businesswire.com/news/home/20210513005311/en/%C2%A0Flare-Therapeutics-Launches-with-82-Million-Series-A-Financing-to-Advance-Precision-Oncology-Pipeline-based-on-Novel-Drug-Discovery-Approach-for-Transcription-Factors
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com